M Kudo Selected Research

M Kudo Research Topics

Disease

24	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 03/2001
13	Neoplasms (Cancer) 12/2023 - 01/2001
7	Hypertension (High Blood Pressure) 01/2017 - 07/2001
5	Inflammation (Inflammations) 01/2017 - 03/2005
4	Ischemia 11/2001 - 01/2000
3	Hyperaldosteronism (Conn Syndrome) 01/2016 - 10/2015
3	Infections 10/2011 - 09/2001
3	Gastritis 04/2003 - 01/2000
3	Stomach Neoplasms (Stomach Cancer) 04/2003 - 04/2001
3	Brain Injuries (Brain Injury) 09/2001 - 06/2000
2	Disease Progression 12/2023 - 01/2017
2	Non-alcoholic Fatty Liver Disease 12/2022 - 12/2021
2	Liver Neoplasms (Liver Cancer) 01/2017 - 10/2013
2	Fibrosis (Cirrhosis) 01/2017 - 06/2001
2	Chronic Pancreatitis 01/2017 - 01/2016
2	Liver Diseases (Liver Disease) 01/2017 - 10/2011
2	Pancreatitis 01/2017 - 01/2016
2	Adenoma (Adenomas) 01/2016 - 02/2011
2	Pain (Aches) 02/2015 - 06/2005
2	Chronic Hepatitis C 10/2011 - 06/2009
2	Virus Diseases (Viral Diseases) 10/2011 - 06/2009
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2006 - 03/2005
2	Ulcer 04/2003 - 04/2003
2	Metaplasia 04/2003 - 04/2003
2	Atherosclerosis 12/2001 - 07/2001
2	Colonic Neoplasms (Colon Cancer) 09/2001 - 04/2001
2	Neoplasm Metastasis (Metastasis) 09/2001 - 01/2001
2	Colorectal Neoplasms (Colorectal Cancer) 04/2001 - 04/2001
1	Thrombosis (Thrombus) 12/2021
1	Autoimmune Pancreatitis 12/2020
1	Dysbiosis 12/2020
1	Hand-Foot Syndrome 01/2017
1	Colitis 11/2014
1	Crohn Disease (Crohn's Disease) 11/2014
1	Carcinogenesis 06/2012

Drug/Important Bio-Agent (IBA)

11	Sorafenib (BAY 43-9006)FDA Link 02/2024 - 07/2010
4	LigandsIBA 01/2016 - 02/2000
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2021 - 12/2001
3	Prednisolone (Predate)FDA LinkGeneric 12/2020 - 09/2001
3	InterferonsIBA 12/2020 - 12/2007
3	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 10/2013
3	ReninIBA 01/2016 - 10/2015
3	AldosteroneIBA 01/2016 - 02/2011
3	Contrast MediaIBA 12/2001 - 08/2001
3	Anesthetics (Anesthetic Agents)IBA 09/2001 - 10/2000
2	lenvatinibIBA 12/2022 - 12/2021
2	InterleukinsIBA 12/2020 - 01/2016
2	Interleukin-13IBA 01/2017 - 01/2016
2	Interleukin-33IBA 01/2017 - 01/2016
2	Immune Checkpoint InhibitorsIBA 11/2016 - 12/2015
2	NucleotidesIBA 01/2016 - 11/2014
2	Fluorouracil (Carac)FDA LinkGeneric 10/2013 - 12/2007
2	JNK Mitogen-Activated Protein KinasesIBA 06/2012 - 01/2000
2	Glycoproteins (Glycoprotein)IBA 01/2010 - 02/2000
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2005 - 09/2001
2	Isoflurane FDA LinkGeneric 01/2005 - 10/2000
2	Fentanyl (Sublimaze)FDA LinkGeneric 10/2004 - 10/2000
2	SterigmatocystinIBA 04/2003 - 04/2003
2	GastrinsIBA 04/2003 - 04/2003
2	SuspensionsIBA 04/2003 - 04/2003
2	Coloring Agents (Dyes)IBA 12/2001 - 08/2001
2	AntibodiesIBA 11/2001 - 01/2000
2	Monoclonal AntibodiesIBA 09/2001 - 04/2001
2	SHU 508 (Levovist)IBA 09/2001 - 03/2001
1	tremelimumabIBA 02/2024
1	durvalumabIBA 02/2024
1	B7-H1 AntigenIBA 12/2023
1	NivolumabIBA 12/2023
1	atezolizumabIBA 12/2022
1	Bevacizumab (Avastin)FDA Link 12/2022
1	BilirubinIBA 12/2021
1	AlbuminsIBA 12/2021
1	16S Ribosomal RNAIBA 12/2020
1	CytokinesIBA 01/2017
1	TrypsinogenIBA 01/2017
1	regorafenibIBA 10/2016
1	CeruletideIBA 01/2016
1	Interleukin-4 (Interleukin 4)IBA 01/2016
1	AngiotensinsIBA 01/2016
1	Cholecystokinin Receptors (Cholecystokinin Receptor)IBA 01/2016
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2015
1	Axitinib (AG 013736)IBA 12/2015
1	Quisqualic AcidIBA 02/2015
1	Glutamate Receptors (Glutamate Receptor)IBA 02/2015
1	Excitatory Amino AcidsIBA 02/2015
1	Glutamic Acid (Glutamate)FDA Link 02/2015
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 11/2014
1	Interleukin-8 (Interleukin 8)IBA 10/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2011
1	Interleukin-6 (Interleukin 6)IBA 10/2011
1	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2011

Therapy/Procedure

15	Therapeutics 11/2016 - 07/2000
4	Drug Therapy (Chemotherapy) 01/2017 - 01/2001
2	Adrenalectomy 10/2015 - 02/2011
2	Hysterectomy 01/2006 - 03/2005
2	Anesthesia 01/2005 - 10/2000
1	Immunotherapy 12/2022
1	Remission Induction 12/2020
1	Investigational Therapies (Experimental Therapy) 01/2017
1	Molecular Targeted Therapy 09/2015